Please enable Javascript
Testicular, Penile, and Rare Malignancies
Advertisement
Reviewing the Effects of Chemotherapy Regimens on PFS for Patients With PSCC
Veronica Mollica, MD
Testicular, Penile, and Rare Malignancies
|
April 19, 2024
Dr. Mollica continues her discussion on prognostic factors and clinical outcomes in PSCC.
View More
Insights from Meet-URO 23/I-RARE: Prognostic Factors and Clinical Outcomes in PSCC
Veronica Mollica, MD
Testicular, Penile, and Rare Malignancies
|
April 19, 2024
Dr. Mollica highlights her recent research investigating prognostic factors and clinical outcomes for patients with PSCC.
View More
NSGCTs With Teratoma Negatively Affects Patients in Good, Intermediate Prognosis Groups
Emily Menendez
Testicular, Penile, and Rare Malignancies
|
April 19, 2024
The IGCCCG was used to compare the survival probabilities of patients with testicular GCTs with or without teratoma.
Read More
Utilizing miRNA as a Liquid Biomarker for Malignancy of Small Testicular Masses
Julian Chavarriaga, MD
Testicular, Penile, and Rare Malignancies
|
April 12, 2024
Dr. Julian Chavarriaga describes his study on using miRNA as a liquid biomarker to detect malignancy in testicular masses.
Read More
miRNA as a Liquid Biomarker for GCTs in STMs
Emily Menendez
Testicular, Penile, and Rare Malignancies
|
April 8, 2024
While most STMs are benign, between 13% and 21% are malignant, and distinguishing between them remains a challenge.
Read More
Determining the Utility of ctDNA in Testicular Cancer
Katy Marshall
Testicular, Penile, and Rare Malignancies
|
April 8, 2024
Research into the potential benefits of ctDNA for patients with testicular cancer both before and after diagnosis is lacking.
Read More
Progress Continues for Use of Liquid Biopsies in GU Cancers
Leah Lawrence
Prostate Cancer Diagnostics
|
April 8, 2024
We spoke with several researchers involved in exploring the clinical utility of liquid biopsy for genitourinary cancers.
Read More
Chemotherapy-Induced Peripheral Neuropathy Linked to Worse QOL in Testicular GCT Survivors
Emily Menendez
Testicular, Penile, and Rare Malignancies
|
April 2, 2024
Survivors with high CIPN experienced more side effects compared to those with low CIPN.
Read More
Mastering Minimally Invasive Techniques: Perspective on Robotics With Dr. Sammy Elsamra
David Ambinder, MD
Prostate Cancer
|
March 29, 2024
Drs. Ambinder and Elsamra explore robotic surgery, including its applicability, patient benefits, and evolving role.
Read More
Analyzing Prognostic Factors, Clinical Outcomes in Penile Carcinoma
Katy Marshall
Testicular, Penile, and Rare Malignancies
|
March 21, 2024
The Meet-URO 23/I-RARE registry hosts data from patients with rare genitourinary malignancies.
Read More
Disparities in GU Cancers Recognized, but Slow to Change
Leah Lawrence
Prostate Cancer
|
March 5, 2024
We spoke with clinicians about some of the disparities that exist, why they persist, and what might be done to correct them.
Read More
Efficacy, Safety of Neoadjuvant Chemotherapy for Patients With PSCC
Katy Marshall
Testicular, Penile, and Rare Malignancies
|
February 22, 2024
Researchers analyzed the data of patients with locally advanced PSCC and clinical lymph node metastasis.
Read More
Can Extended Surveillance, CT Scans Prevent Overtreatment in Patients With CS I NSGCT?
Emily Menendez
Testicular, Penile, and Rare Malignancies
|
February 12, 2024
The use of surveillance with repeat CT scans can accurately identify patients with true CS I.
Read More
Tumor-Informed ctDNA Analysis as a Biomarker for Event-Free Survival in Testicular Cancer
Katy Marshall
ASCO GU Symposium 2024
|
January 24, 2024
The retrospective analysis evaluated 145 plasma samples from 35 patients with stage I, II, and III testicular cancer.
Read More
AUA Releases Updated Guidelines for Diagnosis, Treatment of Early-Stage Testicular Cancer
Katy Marshall
Testicular, Penile, and Rare Malignancies
|
January 5, 2024
The updated guidelines include strong, moderate, and conditional recommendations for clinicians.
Read More
Nuances of Testicular Cancer Care: More Work Needed
Leah Lawrence
Testicular, Penile, and Rare Malignancies
|
February 2, 2024
Testicular cancer experts discuss current practices and challenges related to staging, treatment, and survivorship.
Read More
Does Surgically Treated Cryptorchidism Correspond With Testicular Tumor Pathology?
Katy Marshall
Testicular, Penile, and Rare Malignancies
|
December 21, 2023
Researchers reviewed data from patients with testicular cancer between 2003 and 2020, including orchiectomy patients.
Read More
Simultaneous Optimization of Organ Transplant Rates, Urologic Cancer Outcomes
Zachary Bessette
SUO 2023
|
December 18, 2023
Drs. Pierorazio and Eggener moderated a session on simultaneous optimization of organ transplant and GU cancer outcomes.
Read More
Open Versus Robotic RPLND in Clinical Stage II Testicular Cancer
Zachary Bessette
SUO 2023
|
January 11, 2024
R-RPLND may offer lower morbidity and improved perioperative outcomes than O-RPLND for patients with CS II testicular cancer.
Read More
The Patient Journey Following Testicular Mass Diagnosis: Insights From Dr. Aditya Bagrodia
David Ambinder, MD
Testicular, Penile, and Rare Malignancies
|
October 30, 2023
From presentation with a testicular mass to treatment options, this provides valuable insights for community oncologists.
Read More
Load More
Advertisement
Advertisement
Advertisement